Follow
Andreas Bikfalvi
Andreas Bikfalvi
Verified email at u-bordeaux.fr
Title
Cited by
Cited by
Year
Biological roles of fibroblast growth factor-2
A Bikfalvi, S Klein, G Pintucci, DB Rifkin
Endocrine reviews 18 (1), 26-45, 1997
13681997
Consensus guidelines for the use and interpretation of angiogenesis assays
P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ...
Angiogenesis 21, 425-532, 2018
6102018
Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells
H Bompais, J Chagraoui, X Canron, M Crisan, XH Liu, A Anjo, ...
Blood 103 (7), 2577-2584, 2004
3802004
The role of fibroblast growth factors in vascular development
S Javerzat, P Auguste, A Bikfalvi
Trends in molecular medicine 8 (10), 483-489, 2002
3722002
Inositol-requiring enzyme 1α is a key regulator of angiogenesis and invasion in malignant glioma
G Auf, A Jabouille, S Guérit, R Pineau, M Delugin, M Bouchecareilh, ...
Proceedings of the National Academy of Sciences 107 (35), 15553-15558, 2010
3642010
IRE1 Signaling Is Essential for Ischemia-Induced Vascular Endothelial Growth Factor-A Expression and Contributes to Angiogenesis and Tumor Growth In vivo
B Drogat, P Auguste, DT Nguyen, M Bouchecareilh, R Pineau, ...
Cancer research 67 (14), 6700-6707, 2007
3022007
Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight …
A Bikfalvi, S Klein, G Pintucci, N Quarto, P Mignatti, DB Rifkin
The Journal of cell biology 129 (1), 233-243, 1995
2521995
Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization
C Perollet, ZC Han, C Savona, JP Caen, A Bikfalvi
Blood, The Journal of the American Society of Hematology 91 (9), 3289-3299, 1998
2411998
Low-dose Chemotherapy Combined with an Antiangiogenic Drug Reduces Human Glioma Growth in Vivo
L Bello, G Carrabba, C Giussani, V Lucini, F Cerutti, F Scaglione, ...
Cancer research 61 (20), 7501-7506, 2001
2402001
Accessing key steps of human tumor progression in vivo by using an avian embryo model
M Hagedorn, S Javerzat, D Gilges, A Meyre, B de Lafarge, A Eichmann, ...
Proceedings of the national academy of sciences 102 (5), 1643-1648, 2005
2332005
Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis
JW Shin, M Min, F Larrieu-Lahargue, X Canron, R Kunstfeld, L Nguyen, ...
Molecular biology of the cell 17 (2), 576-584, 2006
2272006
Recent advances in angiogenesis, anti-angiogenesis and vascular targeting
A Bikfalvi, R Bicknell
Trends in pharmacological sciences 23 (12), 576-582, 2002
2152002
The host inflammatory response promotes liver metastasis by increasing tumor cell arrest and extravasation
P Auguste, L Fallavollita, N Wang, J Burnier, A Bikfalvi, P Brodt
The American journal of pathology 170 (5), 1781-1792, 2007
2102007
Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors
S North, M Moenner, A Bikfalvi
Cancer letters 218 (1), 1-14, 2005
2082005
Molecular mechanisms of tumor vascularization
P Auguste, S Lemiere, F Larrieu-Lahargue, A Bikfalvi
Critical reviews in oncology/hematology 54 (1), 53-61, 2005
2032005
Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and-independent mechanisms
P Auguste, DB Gürsel, S Lemiere, D Reimers, P Cuevas, F Carceller, ...
Cancer research 61 (4), 1717-1726, 2001
2032001
HDAC4 represses p21WAF1/Cip1 expression in human cancer cells through a Sp1-dependent, p53-independent mechanism
D Mottet, S Pirotte, V Lamour, M Hagedorn, S Javerzat, A Bikfalvi, ...
Oncogene 28 (2), 243-256, 2009
1902009
Target molecules for anti-angiogenic therapy: from basic research to clinical trials
M Hagedorn, A Bikfalvi
Critical reviews in oncology/hematology 34 (2), 89-110, 2000
1882000
Deciphering the complex role of thrombospondin-1 in glioblastoma development
T Daubon, C Léon, K Clarke, L Andrique, L Salabert, E Darbo, R Pineau, ...
Nature communications 10 (1), 1146, 2019
1862019
CXCR3, a double-edged sword in tumor progression and angiogenesis
C Billottet, C Quemener, A Bikfalvi
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1836 (2), 287-295, 2013
1852013
The system can't perform the operation now. Try again later.
Articles 1–20